Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Potentially Resectable”

117 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 117 results

Large-scale testing (Phase 3)UnknownNCT04552093
What this trial is testing

Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT)

Who this might be right for
Colorectal Neoplasms
The Netherlands Cancer Institute 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT04379739
What this trial is testing

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 89
Not applicableStudy completedNCT02818907
What this trial is testing

Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable

Who this might be right for
Pancreatic Cancer
Centre Hospitalier Universitaire de Besancon 290
Not applicableLooking for participantsNCT06448793
What this trial is testing

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 55
Large-scale testing (Phase 3)Study completedNCT01516944
What this trial is testing

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Hebei Medical University 749
Large-scale testing (Phase 3)Not Yet RecruitingNCT07463313
What this trial is testing

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

Who this might be right for
Thymoma and Thymic Carcinoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 116
Large-scale testing (Phase 3)UnknownNCT01523015
What this trial is testing

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal Junction
Medical University of Lublin 100
Testing effectiveness (Phase 2)Study completedNCT04221555
What this trial is testing

Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Asan Medical Center 68
Testing effectiveness (Phase 2)Study completedNCT00030745
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

Who this might be right for
Malignant Mesothelioma
Swiss Cancer Institute 61
Large-scale testing (Phase 3)Looking for participantsNCT06355427
What this trial is testing

The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Mara Veenstra, MD 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT05177068
What this trial is testing

Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer
Henan Cancer Hospital 42
Testing effectiveness (Phase 2)Study completedNCT00557102
What this trial is testing

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute, France 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05151588
What this trial is testing

Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma

Who this might be right for
Sinonasal Carcinoma
Dr. Victor H.F. Lee 30
Not applicableActive Not RecruitingNCT06243679
What this trial is testing

The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC

Who this might be right for
Resectable/Potentially Resectable NSCLC
Xiangya Hospital of Central South University 100
Post-approval studies (Phase 4)UnknownNCT02380131
What this trial is testing

Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis

Who this might be right for
HER-2 Positive Gastric CancerLiver Metastasis
Hebei Medical University 60
Not applicableNot Yet RecruitingNCT07034703
What this trial is testing

Prospective Cohort of Patients Treated Using Neoadjuvant Modified FOLFIRINOX 6 Cycles for Potentially Resectable Pancreatic Duct Adenocarcinoma, Candidate for Participation in the PANACHE02 Clinical Trial

Who this might be right for
Resectable Pancreatic Duct Adenocarcinoma
University Hospital, Rouen 820
Large-scale testing (Phase 3)Not Yet RecruitingNCT06796803
What this trial is testing

Camrelizumab Combined with Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) As Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)

Who this might be right for
Potentially Resectable Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 398
Testing effectiveness (Phase 2)Active Not RecruitingNCT07274761
What this trial is testing

Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.

Who this might be right for
Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung CancerNon Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 24
Very early researchStudy completedNCT02550327
What this trial is testing

Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Baylor Research Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT05503667
What this trial is testing

Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma Stage IIILung Adenocarcinoma Stage IVEGFR Gene Mutation
Shanghai Pulmonary Hospital, Shanghai, China 96
Load More Results